← Back to Clinical Trials
Recruiting NCT05773898

NCT05773898 Contribution of Psychological Autopsy to the Understanding of Suicidal Behaviors in French Overseas Territories

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05773898
Status Recruiting
Phase
Sponsor University Hospital Center of Martinique
Condition Suicide
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2024-01-25
Primary Completion 2025-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
other

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2024-01-25 with a primary completion date of 2025-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The mains objectives of our project are to coordinate the monitoring of suicides and to identify common or specific suicide risk factors in four overseas DROM-COM (French Polynesia, La Reunion, French Guiana and Martinique) by comparing to a site in mainland France (Amiens). A mixed approach (quantitative and qualitative) will be used, based on semi-directed interviews of the psychological autopsy type.

Eligibility Criteria

Inclusion Criteria: * Persons close of the deceased * Persons who knew about his/her childhood * Age 18 or over * Interviewed for the study between 2 and 11 months after the suicide Exclusion Criteria: * People with neuropsychiatric disorders that may affect the quality of the information collected, cognitive (memory and expression) and judgmental functions * People who refuses to participate * Persons referred to articles L.1121-6, L.1121-7, L. 1121-8 L.1121-1-2 of the French Public Health Code.

Contact & Investigator

Central Contact

SEBASTIEN CAVALINI

✉ sebastien.cavalini@chu-martinique.fr

📞 +596 596 592 696

Principal Investigator

STEPHANE AMADEO, Pr

PRINCIPAL INVESTIGATOR

University hospital, Martinique

Frequently Asked Questions

Who can join the NCT05773898 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05773898 currently recruiting?

Yes, NCT05773898 is actively recruiting participants. Contact the research team at sebastien.cavalini@chu-martinique.fr for enrollment information.

Where is the NCT05773898 trial being conducted?

This trial is being conducted at Fort-de-France, Martinique.

Who is sponsoring the NCT05773898 clinical trial?

NCT05773898 is sponsored by University Hospital Center of Martinique. The principal investigator is STEPHANE AMADEO, Pr at University hospital, Martinique. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology